US Firm Uses Fungi To Develop Formula To Break Plastic In Baby Diapers
A US-based start-up has come up with a sustainable solution for environmental issues linked to disposable diapers. The company, Hiro Technologies, said that they have developed MycoDigestible Diapers, which is a fungi-powered decomposition technology. The Texas startup company said that baby poop and fungi would work together to break down the plastic.
"We have figured out how to collaborate with nature's ancient technology — decomposer fungi — to support the breakdown of the HIRO Diaper," the website of Hiro Technologies noted.
How will this disposable diaper work?
The company said that each MycoDigestible Diaper comes with a packet of fungi, which is supposed to be added to the dirty diaper before throwing it away. The fungi are activated by moisture from faeces, urine and the environment to begin the process of biodegradation after a week or two.
The company is selling "diaper bundles" for $35 a week online.
Disposable diapers contribute significantly to landfill waste, taking up to 300-500 years to decompose. They emit greenhouse gas methane and contaminate groundwater. If not disposed of properly, the diapers can also pollute water bodies and spread viruses and bacteria.
The company said that they analysed the stages of decomposition of a treated diaper over time in three sealed jars. The product looked like black soil in nine months.
Scientists have conducted several studies to understand various aspects of fungi. Earlier this year, in February, a study found that a Hawaiian marine fungus is capable of plastic degradation.
Researchers at Yale University in 2011 identified a fungus (Pestalotiopsis microspora) that is capable of consuming polyurethane, a plastic polymer.
Drawbacks of using diapers
Several health experts have said that chemicals and synthetic materials in disposable diapers can cause skin irritation, allergic reactions and rashes. Infrequent changing and prolonged exposure to urine and stool can lead to diaper rash, regardless of the diaper type.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
Axiom-4 astronauts to study insulin behaviour in microgravity, revolutionise diabetes treatment
New Delhi: Indian astronaut Shubhanshu Shukla's Axiom-4 mission to the International Space Station (ISS) is set to offer a ray of hope for diabetics to travel to space, as a UAE-based healthcare provider is conducting an experiment on how glucose behaves in microgravity part of the "Suite Ride" experiment planned by Burjeel Holdings and Axiom Space, some astronauts of the Axiom-4 mission will be wearing continuous glucose monitors during their 14-day stay on board the orbital lab. The studies of the behaviour of glucose and insulin in microgravity conditions will help scientists develop wearable technologies for astronauts and patients who are bedridden or have limited mobility due to illnesses such as paralysis. "We are trying just to see if there is any change or fluctuation to the blood-sugar levels while they are in space," Mohammad Fityan, chief medical officer at Burjeel Holdings, Abu Dhabi, told PTI. The astronauts will also carry insulin pens in refrigerated and ambient temperatures to examine how the molecules respond to microgravity conditions. "We are hoping that if we learn something about the metabolism or the effect, we will bring some information and we can do something for our patients on Earth," Fityan said. Currently, the National Aeronautics and Space Administration (NASA) does not allow insulin-dependent diabetics to travel to space. There are no official exclusions for non-insulin-dependent diabetics, but so far, no astronaut with diabetes has travelled to space. "It has the potential to transform the future of space travel for astronauts with insulin-dependent diabetes mellitus (IDDM), a condition historically considered disqualifying for space missions," Fityan said. He said the study will pave the way for several innovative technologies and treatment approaches for developing advanced glucose-monitoring tools optimised for extreme or low-activity environments, improving wearable tech for both astronauts and patients with limited mobility on Earth. It will also help identify new pharmacologic targets by observing how metabolic and hormonal responses change in microgravity, leading to drugs that enhance insulin sensitivity or mimic the benefits of exercise in sedentary individuals. The AI-powered predictive models based on real-time physiologic data in space can be adapted to personalise diabetes care on Earth by forecasting insulin needs or metabolic shifts with higher accuracy. The research will also help develop remote monitoring platforms for continuous metabolic-data capture that could revolutionise diabetes care in underserved or remote areas on Earth as well as in tele-health settings.
Time of India
4 hours ago
- Time of India
Major chocolate recall sweeps U.S stores — here's why your favorite sweet treat might be unsafe
Weaver Nut Company is recalling certain semi-sweet chocolate nonpareils distributed throughout the United States. If you recently purchased semi-sweet chocolate nonpareils from a grocery or retail store, you should double-check the lot number. Major chocolate recall sweeps U.S. stores: The U.S. Food and Drug Administration (FDA) announced in a news release on Wednesday that Weaver Nut Company was recalling its semi-sweet chocolate nonpareils with white or Christmas-colored seeds, with particular lot codes, due to possible unreported milk allergies, as per a report by Newsweek. Although no illnesses have been reported, people who are allergic to milk face a serious risk. The chocolates were sold through supermarkets and retail stores throughout the United States. ALSO READ: McDonald's boycott June 24: Who's behind it, why it's happening, and how long it will last Why is your favourite sweet treat unsafe? According to the FDA's release, the problem was discovered after a wholesale customer complained about differences in product specifications. Live Events The chocolates were labelled as being free of milk, but later laboratory testing revealed that they did contain milk proteins, it added. It further stated that consuming the affected items could result in severe or fatal allergic reactions for people with a milk allergy or severe sensitivity. One of the top nine allergens that the FDA requires to be declared is milk, and improper labelling can be very risky. Why is this recall important? According to the Pennsylvania-based Weaver Nut Company, the recall is a preventative step to protect the public's health. The business is taking all necessary steps to ensure the safety of its products. Which chocolates are affected? Customers are advised to verify product lot codes and return or dispose of any impacted items. Throw away the items or return them to the store for a complete refund. Lot numbers 204206, 204207, 204208, 204209, 204212, 224225 are for Item 47518-Nonpareil, Semi-Sweet Chocolate (Christmas Seeds). Lot numbers 204214-RL, 204214, 204215, 224221, 224222, 224223, 135215, 135216, 135217, 135220, 135221, 145204, 145205-1, 145207-1, and 145210-1 are for Item D2645, Nonpareils, Semi-Sweet Chocolate (White Seeds), as per a report by Newsweek. FAQs What do I do if I have these chocolates? Check the lot number, and if it is recalled, do not eat it. Return it for a refund or dispose of it. Why is the recall so serious? Milk is a major allergen, and consuming it when allergic can result in serious or life-threatening reactions. Economic Times WhatsApp channel )
Mint
5 hours ago
- Mint
Fighter jet maker Hindustan Aeronautics Limited bags transfer of technology of SSLV from ISRO for ₹511 crore
In a significant milestone, Hindustan Aeronautics Limited (HAL) was on Friday declared the winner of the bid for the transfer of technology of the Small Satellite Launch Vehicle (SSLV), the Indian Space Research Organisation's (ISRO) rocket to place satellites up to 500 kg in low-earth orbit, edging out two consortia. According to a PTI report, fighter jet manufacturer HAL was the standalone bidder for the coveted contract to build the ISRO-designed rocket and was pitted against the two consortia – one led by Alpha Design Technologies, backed by the Adani Group, and the other led by Hyderabad-based Bharat Dynamics Limited. In a message on X, HAL said that it will be responsible for absorbing, manufacturing and commercialising SSLV technology. 'HAL's selection for the SSLV ToT will enable indigenous production and further development of small satellite launch capabilities, opening up new partnerships with domestic and international satellite operators,' Dr DK Sunil, Chairman and Managing Director of HAL, said. HAL presented the winning bid of ₹ 511 crore to emerge as the sole manufacturer of the SSLV after the completion of the process of transfer of technology that is expected to take place over the next two years, the PTI report said. "Under this technology-transfer agreement, HAL will have the capability to independently build, own and commercialise SSLV launches," Pawan Kumar Goenka, chairman, Indian National Space Promotion and Authorisation Centre (INSPACe), told a press conference in New Delhi. HAL will be the third company to build rockets after space sector start-ups Skyroot Aerospace and Agnikul Cosmos, the report added. Goenka said nine companies had evinced interest in the transfer of technology of the SSLV, of which three were rejected. Of the remaining six, three chose not to apply. "The SSLV technology transfer marks a pivotal moment in India's transformative commercial space segment, as this is one of the first instances of a space agency transferring complete launch vehicle technology to a company," he said. Goenka said that ISRO will handhold HAL and assist it in building two prototype rockets over the next two years. After that, the state-owned company is expected to independently produce six to 10 SSLVs every year, depending on the demand. "HAL will be free to improve on the design and select its own vendors from the third rocket after the two-year period," Goenka said. According to HAL, SSLV is a compact, cost-effective, and highly flexible launch vehicle developed by ISRO to address the rapidly growing demand for launching small satellites into Low Earth Orbit. The SSLV was developed by the ISRO to launch small satellites into low-earth orbit at a shorter notice, a capability required by the defence forces in times of emergencies. "This collaboration marks a significant step towards strengthening India's commercial satellite-launch capabilities and more specifically, in enabling Indian industry in realising this SSLV," Radhakrishnan Durairaj, Chairman and Managing Director of New Space India Limited (NSIL), said. According to the PTI report, the move is part of efforts to allow the ISRO to focus more on research and hive off the routine activities of launching satellites, using proven launch vehicles to the industry. "We are looking forward to working closely under the ISRO and IN-SPACe's guidance to progress in phases and realise the end objectives. We are confident of steering a cohesive ecosystem that enables more small satellite launches from India's ports," DK Sunil, CMD, HAL, said. The technology-transfer agreement will be signed among HAL, NSIL, ISRO and IN-SPACe.
